Quince Therapeutics Inc
NASDAQ:QNCX

Watchlist Manager
Quince Therapeutics Inc Logo
Quince Therapeutics Inc
NASDAQ:QNCX
Watchlist
Price: 1.54 USD -3.75%
Market Cap: 70m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+55%
Revenue
Forecast
+12%
Operating Income
Forecast
+12%
Net Income
Forecast
+16%

Wall Street
Price Targets

QNCX Price Targets Summary
Quince Therapeutics Inc

Wall Street analysts forecast QNCX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for QNCX is 7.4 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.

QNCX Lowest Forecast
Wall Street Target
4.04 USD
162% Upside
QNCX Average Forecast
Wall Street Target
7.4 USD
380% Upside
QNCX Highest Forecast
Wall Street Target
10.5 USD
582% Upside
Lowest
Price Target
4.04 USD
162% Upside
Average
Price Target
7.4 USD
380% Upside
Highest
Price Target
10.5 USD
582% Upside
Quince Therapeutics Inc Competitors:
Price Targets
D
688192
Dizal Jiangsu Pharmaceutical Co Ltd
16% Upside
BIOCON
Biocon Ltd
11% Upside
4882
Perseus Proteomics Inc
100% Upside
BEAM
Beam Therapeutics Inc
165% Upside
D
688192
Dizal Jiangsu Pharmaceutical Co Ltd
16% Upside
BIOCON
Biocon Ltd
11% Upside
4882
Perseus Proteomics Inc
100% Upside
BEAM
Beam Therapeutics Inc
165% Upside
K
2162
KeyMed Biosciences Inc
27% Upside
BMRN
Biomarin Pharmaceutical Inc
81% Upside
M
MAB
Mabion SA
4% Downside
ITOS
Iteos Therapeutics Inc
19% Upside

Revenue
Forecast

Revenue Estimate
Quince Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Quince Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Quince Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss
What are analyst estimates?

See Also

Summary
QNCX intrinsic value, competitors valuation, and company profile.
DCF Valuation
QNCX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
QNCX stock valuation using valuation multiples.
Wall Street Estimates
QNCX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
QNCX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is QNCX's stock price target?
Price Target
7.4 USD

According to Wall Street analysts, the average 1-year price target for QNCX is 7.4 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.

Back to Top
ALPHA SPREAD
Follow us
Join more than 264,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.